“…Matrix remodeling is achieved by the tight regulation of production and degradation of its components; whilst this metabolism is normally slow, select challenges like growth [ 48 ], cell division [ 49 ] and migration [ 50 , 51 ], inflammation [ 52 , 53 ] or injury [ 54 , 55 , 56 ] enhance matrix transformation. Many enzymes contribute to this process, most notably members of the matrix metalloprotease family (MMPs) and their regulators: tissue inhibitors of metalloproteinases (TIMPs), tissue plasminogen activator (tPA), plasminogen activator inhibitor, ADAMTS family, the hyaluronidase/chondroitinase family [ 57 , 58 ] and their various subtypes [ 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 ]. MMPs are endopeptidases which have a dominant role in extracellular matrix degradation in vivo.…”